Skip to main content
. 2020 Feb 11;12(2):199. doi: 10.3390/v12020199

Figure 3.

Figure 3

Human immunodeficiency virus (HIV-1) entry inhibition by LUMS1: dose-response curve showing inhibition of pseudo-typed virus, HIV-1 strain HXB2, by LUMS1 and MVN. The proteins at varying concentration was mixed with the virus at 37 °C followed by the addition of TZM-bl. After 48 h, cells were lysed, and percent infection was measured through luciferase activity. The assay was performed in triplicates.